| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/2011 | US20110092419 Protease-stabilized insulin analogues |
| 04/21/2011 | US20110092418 Chimeric Relaxin Polypeptides Comprising an A and B Chain Derived From Different Relaxin Family Peptides |
| 04/21/2011 | US20110092417 Leptin fusion proteins |
| 04/21/2011 | US20110092416 Vitamine B12 - Peptide Conjugates for Oral Delivery |
| 04/21/2011 | US20110092415 Anti-Viral Compounds |
| 04/21/2011 | US20110092414 Composition for treating virus infection disease comprising jab1 |
| 04/21/2011 | US20110092413 Albumin-Fused Kunitz Domain Peptides |
| 04/21/2011 | US20110092412 Method of producing tat-hoxb4h |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091584 Lymphatic vessel stabilizer |
| 04/21/2011 | US20110091570 Compositions and Devices for Antisepsis and Anticoagulation |
| 04/21/2011 | US20110091565 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| 04/21/2011 | US20110091561 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 04/21/2011 | US20110091553 Method for producing microcapsules using solid fat |
| 04/21/2011 | US20110091550 Methods for Promoting the Revascularization and Reenervation of CNS Lesions |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |
| 04/21/2011 | US20110091527 Compositions and methods for reducing scar formation in wound healing |
| 04/21/2011 | US20110091525 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 04/21/2011 | US20110091524 Biomarkers for sensitivity to anti-igf1r therapy |
| 04/21/2011 | US20110091523 Cochleate compositions directed against expression of proteins |
| 04/21/2011 | US20110091516 Muscle-based grafts/implants |
| 04/21/2011 | US20110091510 Nanorod materials and methods of making and using same |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091506 Vaccine compositions |
| 04/21/2011 | US20110091505 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091504 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091501 Recombinant Rhinovirus Vectors |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 04/21/2011 | US20110091488 Water-swellable polymers |
| 04/21/2011 | US20110091485 Modulation of cell junctions |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091482 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| 04/21/2011 | US20110091481 Biomarkers for predicting response to immunosuppressive therapy |
| 04/21/2011 | US20110091474 Compositions and Methods For Diagnosing and Treating Diabetic Micro Vascular Complications |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |
| 04/21/2011 | US20110091452 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies |
| 04/21/2011 | US20110091450 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies |
| 04/21/2011 | US20110091448 Methods for regulation of stem cells |
| 04/21/2011 | US20110091443 Heparin-conjugated fibrin gel and method and kit for preparing same |
| 04/21/2011 | US20110091442 Novel compositions for preventing and/or treating lysosomal storage disorders |
| 04/21/2011 | US20110091441 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 04/21/2011 | US20110091440 Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases |
| 04/21/2011 | US20110091439 Cosmetic use of acid ceramidase type proteins |
| 04/21/2011 | US20110091438 Radioprotective sod soluble isoform and uses thereof |
| 04/21/2011 | US20110091437 Fusion proteins |
| 04/21/2011 | US20110091436 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 04/21/2011 | US20110091435 Phytoestrogenic formulations for alleviation or prevention of hair loss |
| 04/21/2011 | US20110091423 Compositions and methods of use of ritonavir for treating hcv |
| 04/21/2011 | US20110091422 Use of Genetic Markers for Identifying the Response to Interferon Treatment in Multiple Sclerosis Patients |
| 04/21/2011 | US20110091421 Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases |
| 04/21/2011 | US20110091420 Injectable Sustained-Release Pharmaceutical Formulation and the Preparation Method Thereof |
| 04/21/2011 | US20110091419 Use of Pegylated IL-10 to Treat Cancer |
| 04/21/2011 | US20110091418 Methods for treating viral infections using polyamine analogs |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091416 Immunoglobulin fusion proteins |
| 04/21/2011 | US20110091415 Hydroxyethyl Starch-Containing Polypeptide Compositions |
| 04/21/2011 | US20110091414 Stabilized compositions of proteins having a free thiol moiety |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091412 Mutant interleukin-2 (il-2) polypeptides |
| 04/21/2011 | US20110091411 Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases |
| 04/21/2011 | US20110091410 Engineered CXCL12 Alpha Locked Dimer Polypeptide |
| 04/21/2011 | US20110091405 Composition and methods for promoting lush hair growth |
| 04/21/2011 | US20110091403 Oligosaccharide aldonic acids and their topical use |
| 04/21/2011 | US20110091380 Chlorotoxins as drug carriers |
| 04/21/2011 | US20110091378 Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists |
| 04/21/2011 | US20110091375 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 04/21/2011 | DE102009049702A1 Verwendung von Lactoferrin und Lactoferrin enthaltende Zusammensetzungen Use of lactoferrin and lactoferrin containing compositions |
| 04/21/2011 | CA2813740A1 Recombinant human cc10 protein for treatment of influenza |
| 04/21/2011 | CA2777845A1 Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation |
| 04/21/2011 | CA2777752A1 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide |
| 04/21/2011 | CA2777717A1 Chimeric fibroblast growth factors with altered receptor specificity |
| 04/21/2011 | CA2777700A1 Improved peptidomimetic macrocycles |
| 04/21/2011 | CA2777699A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | CA2777629A1 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 04/21/2011 | CA2777628A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
| 04/21/2011 | CA2777560A1 Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor |
| 04/21/2011 | CA2777401A1 Stem cells for musculoskeletal tissue repair |
| 04/21/2011 | CA2777400A1 Granulysin in immunotherapy |
| 04/21/2011 | CA2777397A1 Polymeric systems for the delivery of anticancer agents |
| 04/21/2011 | CA2777250A1 Na-k pump modulation |
| 04/21/2011 | CA2777243A1 Use of a neuregulin to treat peripheral nerve injury |
| 04/21/2011 | CA2777240A1 Enteral administration of arginine-glutamine dipeptide to support retinal, intestinal, or nervous system development |
| 04/21/2011 | CA2773975A1 Fat accumulation suppressor |
| 04/20/2011 | EP2312309A2 Chromatography of metal complexes |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311958A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/20/2011 | EP2311956A1 Methods for making APO-2 ligand using divalent metal ions |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |